Understanding the Recent Increase in Ferritin Levels in United States Dialysis Patients: Potential Impact of Changes in Intravenous Iron and Erythropoiesis-Stimulating Agent Dosing.

PubWeight™: 0.89‹?›

🔗 View Article (PMID 26286925)

Published in Clin J Am Soc Nephrol on August 18, 2015

Authors

Angelo Karaboyas1, Jarcy Zee2, Hal Morgenstern3, Jacqueline G Nolen4, Raymond Hakim5, Kamyar Kalantar-Zadeh6, Philip Zager7, Ronald L Pisoni2, Friedrich K Port2, Bruce M Robinson8

Author Affiliations

1: Arbor Research Collaborative for Health, Ann Arbor, Michigan; Angelo.Karaboyas@ArborResearch.org.
2: Arbor Research Collaborative for Health, Ann Arbor, Michigan;
3: Arbor Research Collaborative for Health, Ann Arbor, Michigan; Departments of Epidemiology and Environmental Health Sciences, School of Public Health, University of Michigan, Ann Arbor, Michigan; Department of Urology and.
4: Vifor Pharma, Glattbrugg, Switzerland;
5: Vanderbilt University, Nashville, Tennessee;
6: University of California-Irvine, Irvine, California; and.
7: University of New Mexico, Albuquerque, New Mexico.
8: Arbor Research Collaborative for Health, Ann Arbor, Michigan; Department of Internal Medicine, Medical School, University of Michigan, Ann Arbor, Michigan;

Articles cited by this

The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol (1986) 124.55

Effect size measures for mediation models: quantitative strategies for communicating indirect effects. Psychol Methods (2011) 5.01

The DOPPS Practice Monitor for US dialysis care: trends through December 2011. Am J Kidney Dis (2012) 3.29

Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortality. Kidney Int (2014) 3.04

IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000. Am J Kidney Dis (2001) 2.85

The Dialysis Outcomes and Practice Patterns Study (DOPPS): design, data elements, and methodology. Am J Kidney Dis (2004) 2.82

The causal mediation formula--a guide to the assessment of pathways and mechanisms. Prev Sci (2012) 2.77

Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat Genet (2014) 2.70

KDOQI US commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD. Am J Kidney Dis (2013) 2.43

Association between serum ferritin and measures of inflammation, nutrition and iron in haemodialysis patients. Nephrol Dial Transplant (2004) 1.91

Early trends from the Study to Evaluate the Prospective Payment System Impact on Small Dialysis Organizations (STEPPS). Am J Kidney Dis (2013) 1.79

Medicare program; end-stage renal disease prospective payment system. Final rule. Fed Regist (2010) 1.47

Iron status in patients receiving erythropoietin for dialysis-associated anemia. Kidney Int (1989) 1.39

The DOPPS practice monitor for U.S. dialysis care: update on trends in anemia management 2 years into the bundle. Am J Kidney Dis (2013) 1.12

Considerations and challenges in defining optimal iron utilization in hemodialysis. J Am Soc Nephrol (2014) 1.11

Serum ferritin is a marker of morbidity and mortality in hemodialysis patients. Am J Kidney Dis (2001) 1.10

Erythropoietin's inhibiting impact on hepcidin expression occurs indirectly. Am J Physiol Regul Integr Comp Physiol (2014) 0.86

Seeking safe and efficacious anemia management. Semin Dial (2009) 0.80